Market Research Logo

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
  • Intelligence on BioMarin Pharmaceutical Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

BioMarin Pharmaceutical (BioMarin or 'the company'), a commercial-stage biopharmaceutical company, develops and commercializes biopharmaceuticals for the treatment of serious diseases and medical conditions. The company operates in the US, Europe and Latin America. It is headquartered in San Rafael, California, and employed 1,341 people as of January 24, 2014.Reasons to Purchase:

  • Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on BioMarin Pharmaceutical Inc.’s business structure, strategy and prospects

  • Company Snapshot
    BioMarin Pharmaceutical Inc.: Company Overview
    BioMarin Pharmaceutical Inc.: Overview and Key Facts
    BioMarin Pharmaceutical Inc.: Overview
    BioMarin Pharmaceutical Inc.: Key Facts
    BioMarin Pharmaceutical Inc.: Key Employees
    BioMarin Pharmaceutical Inc.: Key Employee Biographies
    BioMarin Pharmaceutical Inc.: Major Products and Services
    BioMarin Pharmaceutical Inc.: Company History
    BioMarin Pharmaceutical Inc.: Management Statement
    BioMarin Pharmaceutical Inc.: Locations and Subsidiaries
    BioMarin Pharmaceutical Inc.: Key Competitors
    BioMarin Pharmaceutical Inc.: Company Analysis
    BioMarin Pharmaceutical Inc.: Business Description
    BioMarin Pharmaceutical Inc.: SWOT Analysis
    BioMarin Pharmaceutical Inc.: SWOT Overview
    BioMarin Pharmaceutical Inc.: Strengths
    BioMarin Pharmaceutical Inc.: Weaknesses
    BioMarin Pharmaceutical Inc.: Opportunities
    BioMarin Pharmaceutical Inc.: Threats
    BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity
    BioMarin Pharmaceutical Inc.: Financial Deals Overview
    BioMarin Pharmaceutical Inc.: Targets and Partners
    BioMarin Pharmaceutical Inc.: Top Deals 2011 - 2015YTD*
    BioMarin Pharmaceutical Inc.: Advisors
    BioMarin Pharmaceutical Inc.: Top Legal Advisors
    BioMarin Pharmaceutical Inc.: Top Financial Advisors
    BioMarin Pharmaceutical Inc.: Mergers and Acquisitions
    BioMarin Pharmaceutical Inc.: Corporate Venturing
    BioMarin Pharmaceutical Inc.: Capital Raising
    BioMarin Pharmaceutical Inc.: Partnership
    BioMarin Pharmaceutical Inc.: Recent Developments
    BioMarin Pharmaceutical Inc.: News and Events Summary
    BioMarin Pharmaceutical Inc.: Contracts
    BioMarin Pharmaceutical Inc.: Corporate Governance
    BioMarin Pharmaceutical Inc.: Financial Performance
    BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
    BioMarin Pharmaceutical Inc.: Research & Development
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: BioMarin Pharmaceutical Inc.: Key Facts
    Table 2: BioMarin Pharmaceutical Inc.: Key Employees
    Table 4: BioMarin Pharmaceutical Inc.: Key Competitors
    Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
    Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 8: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
    Table 9: BioMarin Pharmaceutical Inc.: Targets and Partners
    Table 10: BioMarin Pharmaceutical Inc.: Top Deals 2011 - 2015YTD*
    Table 11: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
    Table 12: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
    Table 13: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Table 14: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Table 15: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Table 16: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
    Table 17: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Table 18: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Table 19: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 20: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 21: BioMarin Pharmaceutical Inc.: News and Events Summary
    Table 22: BioMarin Pharmaceutical Inc.: Contracts
    Table 23: BioMarin Pharmaceutical Inc.: Corporate Governance
    Table 24: BioMarin Pharmaceutical Inc.: Financial Performance
    Table 25: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events
    Table 26: BioMarin Pharmaceutical Inc.: Research & Development
    List of Figures
    Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*)
    Figure 3: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 4: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m)
    Figure 5: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Figure 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Figure 7: BioMarin Pharmaceutical Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Figure 8: BioMarin Pharmaceutical Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
    Figure 9: BioMarin Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2011 - YTD*2015)
    Figure 10: BioMarin Pharmaceutical Inc.: Capital Raising by Deal Type (2011 - YTD*2015)
    Figure 11: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 12: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report